Publications by authors named "Burton L Eisenberg"

39Publications

Predictive Biomarkers for Immunotherapy Response Beyond PD-1/PD-L1.

Oncology (Williston Park) 2020 Aug;34(8):321-327

Precision Medicine Program, Hoag Family Cancer Institute, Newport Beach, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.46883/ONC.2020.3408.0321DOI Listing
August 2020

Molecular genomic profiling of adrenocortical cancers in clinical practice.

Surgery 2020 Jul 21. Epub 2020 Jul 21.

Hoag Family Cancer Institute, Precision Medicine Program, Newport Beach, CA; Translational Genomics Research Institution, Phoenix, AZ. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2020.05.039DOI Listing
July 2020

Complete response with talimogene laherparepvec in recurrent melanoma of the ear: A case report.

Oral Oncol 2020 Jul 11:104899. Epub 2020 Jul 11.

Division of Medical Oncology - Head and Neck, USC Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2020.104899DOI Listing
July 2020

The role of margins in extremity soft tissue sarcoma.

J Surg Oncol 2016 Mar 10;113(3):333-8. Epub 2015 Dec 10.

Department of Surgery, Section of Surgical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24112DOI Listing
March 2016

Contemporary Management of Retroperitoneal Soft Tissue Sarcomas.

Curr Oncol Rep 2015 Aug;17(8):39

Department of Surgery, Section of Surgical Oncology, University of Southern California, Keck School of Medicine, 1510 San Pablo Street, Suite 412, 90033, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-015-0462-0DOI Listing
August 2015

Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.

J Clin Oncol 2015 Jul 9;33(20):2231-8. Epub 2015 Feb 9.

Dian Wang, Rush University Medical Center, Chicago, IL; Qiang Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Burton L. Eisenberg, Hoag/University of Southern California Norris Cancer Center, Los Angeles, CA; John M. Kane and Anurag K. Singh, Roswell Park Cancer Institute, Buffalo, NY; X. Allen Li and Manpreet Bedi, Medical College of Wisconsin, Milwaukee, WI; David Lucas, University of Michigan, Ann Arbor, MI; Ivy A. Petersen, Mayo Clinic, Rochester, MN; Thomas F. DeLaney, Massachusetts General Hospital, Boston, MA; Carolyn R. Freeman, McGill University Health Centre, Montreal, Quebec; George Dundas, Cross Cancer Institute, Edmonton, Alberta, Canada; Steven E. Finkelstein, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Ying J. Hitchcock, University of Utah, Salt Lake City, UT; and David G. Kirsch, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.5828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486342PMC
July 2015

Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.

BMC Clin Pathol 2014 22;14:42. Epub 2014 Oct 22.

Departments of Pharmacology & Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, HB-7936, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6890-14-42DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209467PMC
October 2014

A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.

Breast Cancer Res Treat 2013 Feb 16;138(1):175-83. Epub 2013 Feb 16.

Section of Hematology/Oncology, Department of Medicine, Dartmouth-Hitchcock Medical Center, and Norris Cotton Cancer Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2446-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736354PMC
February 2013

The SSG XVIII/AIO trial: results change the current adjuvant treatment recommendations for gastrointestinal stromal tumors.

Am J Clin Oncol 2013 Feb;36(1):89-90

Department of Surgery, Section of Surgical Oncology, Geisel School of Medicine at Dartmouth Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31827a7f55DOI Listing
February 2013

Gastrointestinal stromal tumor--background, pathology, treatment.

Hematol Oncol Clin North Am 2012 Dec;26(6):1239-59

Surgical Oncology, Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2012.08.003DOI Listing
December 2012

Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors.

Int J Cancer 2011 Dec;129(11):2533-42

Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.26234
Publisher Site
http://dx.doi.org/10.1002/ijc.26234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596877PMC
December 2011

Adjuvant and neoadjuvant therapy for primary GIST.

Cancer Chemother Pharmacol 2011 Jan 30;67 Suppl 1:S3-8. Epub 2010 Nov 30.

Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Section of Surgical Oncology, Lebanon, NH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1516-5DOI Listing
January 2011

Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Nutr Cancer 2009 ;61(1):114-22

Department of Medicine, Section of Endocrinology and Metabolism, and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635580802348666DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872989PMC
April 2009

The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.

Cancer Invest 2008 Mar;26(2):118-27

Department of Surgery, Section of Surgical Oncology, Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701522612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768287PMC
March 2008

Combined-modality strategy for gastrointestinal stromal tumors.

Semin Oncol 2006 Dec;33(6 Suppl 11):S75-8

Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2006.10.017DOI Listing
December 2006

Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.

Clin Colorectal Cancer 2006 Nov;6 Suppl 1:S24-9

Department of Surgery, Surgical Oncology, Darthmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/ccc.2006.s.004DOI Listing
November 2006

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

J Clin Oncol 2006 Oct 5;24(29):4764-74. Epub 2006 Sep 5.

Division of Hematology/Oncology, Department of Pathology, Oregon Health & Science University Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.2265DOI Listing
October 2006

Epidemiology of GIST.

Am J Gastroenterol 2005 Oct;100(10):2366

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2005.50650_6.xDOI Listing
October 2005

The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.

Am J Surg 2005 May;189(5):606-9; discussion 609

Department of Surgery, Madigan Army Medical Center, 9040A Reid Street, Tacoma, WA 98431, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2005.01.031DOI Listing
May 2005

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.

Int J Gastrointest Cancer 2003 ;34(2-3):121-8

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/IJGC:34:2-3:121DOI Listing
January 2005

Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.

Int J Radiat Oncol Biol Phys 2004 Jun;59(2):475-80

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2003.10.048DOI Listing
June 2004

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.

Ann Surg Oncol 2004 May;11(5):465-75

Section of Surgical Oncology, Norris Cotton Cancer Center, Rubin Building, 8th Floor, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/ASO.2004.09.011DOI Listing
May 2004

Is reporting of recurrence data important in pancreatic cancer?

Ann Surg Oncol 2004 Mar;11(3):304-9

Department of Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/aso.2004.03.040DOI Listing
March 2004

Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers.

Surg Oncol Clin N Am 2003 Oct;12(4):1015-29

Department of Radiation Oncology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106-6068, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1055-3207(03)00095-4DOI Listing
October 2003

Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors.

Oncology (Williston Park) 2003 Nov;17(11):1615-20; discussion 1620, 1623, 1626 passim

Department of Surgical Oncology, Fox Chase Cancer Center, Temple University, School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
November 2003

Pharmacotherapy of gastrointestinal stromal tumours.

Expert Opin Pharmacother 2003 Jun;4(6):869-74

Department of Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.4.6.869DOI Listing
June 2003

En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

J Gastrointest Surg 2002 Mar-Apr;6(2):147-57; discussion 157-8

Department of Surgical Oncology, Temple University School of Medicine, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1091-255x(01)00063-4DOI Listing
June 2002

Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.

Am Surg 2002 Apr;68(4):337-40; discussion 340-1

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2002